|
1
|
Georgen M, Regimbeau JM, Kianmanesh R,
Marty J, Farges O and Belghiti J: Removal of hepatocellular
carcinoma extending in the right atrium without extracorporal
bypass. J Am Coll Surg. 195:892–894. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee I, Chung JW, Kim HC, Yin YH, So YH,
Jeon UB, Jae HJ, Cho BH and Park JH: Extrahepatic collateral artery
supply to the tumor thrombi of hepatocellular carcinoma invading
inferior vena cava: The prevalence and determinant factors. J Vasc
Interv Radiol. 20:22–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okuda K: Hepatocellular carcinoma:
Clinicopathological aspects. J Gastroenterol Hepatol. 12:S314–S318.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang ZM, Lai EC, Zhang C, Yu HW, Liu Z,
Wan BJ, Liu LM, Tian ZH, Deng H, Sun QH and Chen XP: The strategies
for treating primary hepatocellular carcinoma with portal vein
tumor thrombus. Int J Surg. 20:8–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kudo M, Iznmi N, Kokudo N, Matsui O,
Sakamoto M, Nakashima O, Kojiro M and Makuuchi M; HCC Expert Panel
of Japan Society of Hepatology, : Management of hepatocellular
carcinoma in Japan: Consensus-based clinical practice guidelines
proposed by the Japan Society of Hepatology (JSH) 2010 updated
version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chun YH, Ahn SH, Park JY, Kim DY, Han KH,
Chon CY, Byun SJ and Kim SU: Clinical characteristics and treatment
outcomes of hepatocellular carcinoma with inferior vena cava/heart
invasion. Anticancer Res. 31:4641–4646. 2011.PubMed/NCBI
|
|
7
|
Wang Y, Yuan L, Ge RL, Sun Y and Wei G:
Survival benefit of surgical treatment for hepatocellular carcinoma
with inferior vena cava/right atrium tumor thrombus: Results of a
retrospective cohort study. Ann Surg Oncol. 20:914–922. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sonsuz A: Barcelona clinic liver cancer
(BCLC) staging: Does it cover all our expectation. J Gastrointest
Cancer. 48:260–261. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakamoto K and Nagano H: Outcomes of
surgery for hepatocellular carcinoma with tumor thrombus in the
inferior vena cava or right atrium. Surg Today. 48:819–824. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun JH, Zhang YL, Nie CH, Chen LM, He JD,
Wang WL and Zheng SS: Long-term survival after chemoembolization of
metastatic right atrial tumor thrombus as a presenting feature of
hepatocellular carcinoma: A case study. Oncol Lett. 3:975–977.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawakami M, Koda M, Mandai M, Hosho K,
Murawaki Y, Oda W and Hayashi K: Isolated metastases of
hepatocellular carcinoma in the right atrium: Case report and
review of the literature. Oncol Lett. 5:1505–1508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohwada S, Tanahashi Y, Kawashima Y, Satoh
Y, Nakamura S, Kobayashi I, Ohya T, Ishikawa S, Ohtaki A, Iino Y,
et al: Surgery for tumor thrombi in the right atrium and inferior
vena cava of patients with recurrent hepatocellular carcinoma.
Hepatogastroenterology. 41:154–157. 1994.PubMed/NCBI
|
|
13
|
Nakashima T, Okuda K, Kojiro M, Jimi A,
Yamaguchi R, Sakamoto K and Ikari T: Pathology of hepatocellular
carcinoma in Japan. 232 Consecutive cases autopsied in ten years.
Cancer. 51:863–877. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kojiro M, Nakahara H, Sugihara S, Murakami
T, Nakashima T and Kawasaki H: Hepatocellular carcinoma with
intra-atrial tumor growth. A clinicopathologic study of 18 autopsy
cases. Arch Pathol Lab Med. 108:989–992. 1984.PubMed/NCBI
|
|
15
|
Anthony PP: Primary carcinoma of the
liver: A study of 282 cases in Ugandan Africans. J Pathol.
110:37–48. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Macdonald RA: Primary carcinoma of the
liver; a clinicopathologic study of one hundred eight cases. Ama
Arch Intern Med. 99:266–279. 1957. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koo J, Fung K, Siu KF, Lee NW, Lett Z, Ho
J, Wong J and Ong GB: Recovery of malignant tumor cells from the
right atrium during hepatic resection for hepatocellular carcinoma.
Cancer. 52:1952–1956. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sung AD, Cheng S, Moslehi J, Scully EP,
Prior JM and Loscalzo J: Hepatocellular carcinoma with
intracavitary cardiac involvement: A case report and review of the
literature. Am J Cardiol. 102:643–645. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng HY, Wang XY, Zhao GL and Chen D:
Imaging findings and transcatheter arterial chemoembolization of
hepatic malignancy with right atrial embolus in 46 patients. World
J Gastroenterol. 14:3563–3568. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Miyayama S, Matsui O, Taki K, Minami T,
Ryu Y, Ito C, Nakamura K, Inoue D, Notsumata K, Toya D, et al:
Extrahepatic blood supply to hepatocellular carcinoma: Angiographic
demonstration and transcatheter arterial chemoembolization.
Cardiovasc Intervent Radiol. 29:39–48. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tse HF, Lau CP, Lau YK and Lai CL:
Transesophageal echocardiography in the detection of inferior vena
cava and cardiac metastasis in hepatocellular carcinoma. Clin
Cardiol. 19:211–213. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okada S: How to manage hepatic vein tumour
thrombus in hepatocellular carcinoma. J Gastroenterol Hepatol.
15:346–348. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Asahara T, Itamoto T, Katayama K, Nakahara
H, Hino H, Yano M, Ono E, Dohi K, Nakanishi T, Kitamoto M, et al:
Hepatic resection with tumor thrombectomy for hepatocellular
carcinoma with tumor thrombi in the major vasculatures.
Hepatogastroenterology. 46:1862–1869. 1999.PubMed/NCBI
|
|
25
|
Komatsu S, Kido M, Asari S, Toyama H,
Ajiki T, Demizu Y, Terashima K, Okimoto T, Sasaki R and Fukumoto T:
Particle radiotherapy, a novel external radiation therapy, versus
liver resection for hepatocellular carcinoma accompanied with
inferior vena cava tumor thrombus: A matched-pair analysis.
Surgery. 162:1241–1249. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li AJ, Zhou WP, Lin C, Lang XL, Wang ZG,
Yang XY, Tang QH, Tao R and Wu MC: Surgical treatment of
hepatocellular carcinoma with inferior vena cava tumor thrombus: A
new classification for surgical guidance. Hepatobiliary Pancreat
Dis Int. 12:263–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Miyazaki M, Ito H, Nakagawa K, Shimizu H,
Yoshidome H, Shimizu Y, Ohtsuka M, Togawa A and Kimura F: An
approach to intrapericardial inferior vena cava through the
abdominal cavity, without median sternotomy, for total hepatic
vascular exclusion. Hepatogastroenterology. 48:1443–1446.
2001.PubMed/NCBI
|
|
28
|
Mizuno S, Kato H, Azumi Y, Kishiwada M,
Hamada T, Usui M, Sakurai H, Tabata M, Shimpo H and Isaji S: Total
vascular hepatic exclusion for tumor resection: A new approach to
the intrathoracic inferior vena cava through the abdominal cavity
by cutting the diaphragm vertically without cutting the
pericardium. J Hepatobiliary Pancreat Sci. 17:197–202. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wakayama K, Kamiyama T, Yokoo H, Kakisaka
T, Kamachi H, Tsuruga Y, Nakanishi K, Shimamura T, Todo S and
Taketomi A: Surgical management of hepatocellular carcinoma with
tumor thrombi in the inferior vena cava or right atrium. World J
Surg Oncol. 11:2592013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bi X, Gao J and Cai J: Sorafenib versus
transarterial chemoembolization as adjuvant therapies for patients
with hepatocellular carcinoma and microvascular invasion. J Clin
Oncol. 37 (Suppl 4):S2442019. View Article : Google Scholar
|
|
31
|
Li J, Hou Y, Cai XB and Liu B: Sorafenib
after resection improves the outcome of BCLC stage C hepatocellular
carcinoma. World J Gastroenterol. 22:4034–4040. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Gao J, Zheng SM, Wang Y, Xiang X,
Cheng Q and Zhu J: The efficacy of sorafenib in preventing
hepatocellular carcinoma recurrence after resection: A systematic
review and meta-analysis. Rev Esp Enferm Dig. 112:201–210. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Ke Q, Lin N, Zeng Y and Liu J:
Does postoperative adjuvant transarterial chemoembolization benefit
for all patients with hepatocellular carcinoma combined with
microvascular invasion: A meta-analysis. Scand J Gastroenterol.
54:528–537. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang XP, Liu YC, Chen ZH, Sun JX, Wang K,
Chai ZT, Shi J, Guo WX, Wu MC, Lau WY and Cheng SQ: Postoperative
adjuvant transarterial chemoembolization improves outcomes of
hepatocellular carcinoma associated with hepatic vein invasion: A
propensity score matching analysis. nn Surg Oncol. 26:1465–1473.
2019. View Article : Google Scholar
|
|
35
|
Uemoto K, Doi H, Shiomi H, Yamada K,
Tatsumi D, Yasumoto T, Takashina M, Koizumi M and Oh RJ: Clinical
assessment of micro-residual tumors during stereotactic body
radiation therapy for hepatocellular carcinoma. Anticancer Res.
38:945–954. 2018.PubMed/NCBI
|
|
36
|
Kokudo T, Hasegawa K, Yamamoto S, Shindoh
J, Takemura N, Aoki T, Sakamoto Y, Makuuchi M, Sugawara Y and
Kokudo N: Surgical treatment of hepatocellular carcinoma associated
with hepatic vein tumor thrombosis. J Hepatol. 61:583–588. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kokudo T, Hasegawa K, Matsuyama Y,
Takayama T, Izumi N, Kadoya M, Kudo M, Kubo S, Sakamoto M,
Nakashima O, et al: Liver resection for hepatocellular carcinoma
associated with hepatic vein invasion: A Japanese nationwide
survey. Hepatology. 66:510–517. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kouloulias V, Mosa E, Georgakopoulos J,
Platoni K, Brountzos I, Zygogianni A, Antypas C, Kosmidis P,
Mystakidou K, Tolia M, et al: Three-dimensional conformal
radiotherapy for hepatocellular carcinoma in patients unfit for
resection, ablation, or chemotherapy: A retrospective study.
ScientificWorldJournal. 2013:7801412013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rim CH, Kim CY, Yang DS and Yoon WS:
External beam radiation therapy to hepatocellular carcinoma
involving inferior vena cava and/or right atrium: A meta-analysis
and systemic review. Radiother Oncol. 129:123–129. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Matsuo Y, Yoshida K, Nishimura H, Ejima Y,
Miyawaki D, Uezono H, Ishihara T, Mayahara H, Fukumoto T, Ku Y, et
al: Efficacy of stereotactic body radiotherapy for hepatocellular
carcinoma with portal vein tumor thrombosis/inferior vena cava
tumor thrombosis: Evaluation by comparison with conventional
three-dimensional conformal radiotherapy. J Radiat Res. 57:512–523.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Komatsu S, Fukumoto T, Demizu Y, Miyawaki
D, Terashima K, Niwa Y, Mima M, Fujii O, Sasaki R, Yamada I, et al:
The effectiveness of particle radiotherapy for hepatocellular
carcinoma associated with inferior vena cava tumor thrombus. J
Gastroenterol. 46:913–920. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hou JZ, Zeng ZC, Zhang JY, Fan J, Zhou J
and Zeng MS: Influence of tumor thrombus location on the outcome of
external-beam radiation therapy in advanced hepatocellular
carcinoma with macrovascular invasion. Int J Radiat Oncol Biol
Phys. 84:362–368. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Doi H, Beppu N, Kitajima K and Kuribayashi
K: Stereotactic body radiation therapy for liver tumors: Current
status and perspectives. Anticancer Res. 38:591–599.
2018.PubMed/NCBI
|
|
45
|
Chern MC, Chuang VP, Chern MC, Lin ZH and
Lin YM: Erratum to: Transcatheter arterial chemoembolization for
advanced hepatocellular carcinoma with inferior vena cava and right
atrial tumors. Cardiovasc Intervent Radiol. 32:13212009. View Article : Google Scholar
|
|
46
|
Chung SM, Yoon CJ, Lee SS, Hong S, Chung
JW, Yang SW, Seong NJ, Jang ES, Kim JW and Jeong SH: Treatment
outcomes of transcatheter arterial chemoembolization for
hepatocellular carcinoma that invades hepatic vein or inferior vena
cava. Cardiovasc Intervent Radiol. 37:1507–1515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Koo JE, Kim JH, Lim YS, Park SJ, Won HJ,
Sung KB and Suh DJ: Combination of transarterial chemoembolization
and three-dimensional conformal radiotherapy for hepatocellular
carcinoma with inferior vena cava tumor thrombus. Int J Radiat
Oncol Biol Phys. 78:180–187. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sengodan P, Grewal H and Gandhi S:
Invasive hepatocellular carcinoma with recurrent pulmonary
embolism: Use of AngioVac cannula thrombectomy device for
mechanical aspiration. J Invasive Cardiol. 26:E100–E103.
2014.PubMed/NCBI
|
|
49
|
Nishikawa H, Kita R, Kimura T and Osaki Y:
Transcatheter arterial embolic therapies for hepatocellular
carcinoma: A literature review. Anticancer Res. 34:6877–6886.
2014.PubMed/NCBI
|
|
50
|
Chang JY, Ka WS, Chao TY, Liu TW, Chuang
TR and Chen LT: Hepatocellular carcinoma with intra-atrial tumor
thrombi. A report of three cases responsive to thalidomide
treatment and literature review. Oncology. 67:320–326. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Stotz M, Gerger A, Haybaeck J, Kiesslich
T, Bullock MD and Pichler M: Molecular targeted therapies in
hepatocellular carcinoma: Past, present and future. Anticancer Res.
35:5737–5744. 2015.PubMed/NCBI
|
|
52
|
Simão A, Silva R, Correia L, Caseiro Alves
F, Carvalho A and Nascimento Costa JM: Advanced stage
hepatocellular carcinoma with multiple metastasis and vascular
thrombosis: A case of complete response to sorafenib. Acta Med
Port. 29:139–142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S,
Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety of
sorafenib in patients in the Asia-Pacific region with advanced
hepatocellular carcinoma: A phase III randomised, double-blind,
placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: Sorafenib in advanced hepatocellular carcinoma. N Engl J
Med. 359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li W, Wang Y, Gao W and Zheng J: HCC with
tumor thrombus entering the right atrium and inferior vena cava
treated by percutaneous ablation. BMC Surg. 17:212017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Duan F, Yu W, Wang Y, Liu FY, Song P, Wang
ZJ, Yan JY, Yuan K and Wang MQ: Trans-arterial chemoembolization
and external beam radiation therapy for treatment of hepatocellular
carcinoma with a tumor thrombus in the inferior vena cava and right
atrium. Cancer Imaging. 15:72015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang QH, Zhang W, Liu QX, Liu LX, Wu LL,
Wang JH, Yan ZP and Luo JJ: TACE combined with implantation of
irradiation stent versus TACE combine with bare stent for HCC
complicated by IVCTT. Cardiovasc Intervent Radiol. 39:1280–1288.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Jun CH, Sim DW, Kim SH, Hong HJ, Chung MW,
Cho SB, Park CH, Joo YE, Kim HS, Choi SK and Rew JS: Risk factors
for patients with stage IVB hepatocellular carcinoma and extension
into the heart: Prognostic and therapeutic implications. Yonsei Med
J. 55:379–386. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y
and Makuuchi M: Staging of hepatocellular carcinoma: Assessment of
the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772
patients in Japan. Ann Surg. 245:909–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Daniele B, Annunziata M, Barletta E,
Tinessa V and Di Maio M: Cancer of the Liver Italian Program (CLIP)
score for staging hepatocellular carcinoma. Hepatol Res. 37 (Suppl
2):S206–S209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu J, Wang Y, Zhang D, Liu B and Ou Q:
Comparison of survival and quality of life of hepatectomy and
thrombectomy using total hepatic vascular exclusion and
chemotherapy alone in patients with hepatocellular carcinoma and
tumor thrombi in the inferior vena cava and hepatic vein. Eur J
Gastroenterol Hepatol. 24:186–94. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Igaki H, Nakagawa K, Shiraishi K, Shiina
S, Kokudo N, Terahara A, Yamashita H, Sasano N, Omata M and Ohtomo
K: Three-dimensional conformal radiotherapy for hepatocellular
carcinoma with inferior vena cava invasion. Jpn J Clin Oncol.
38:438–444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Kim HC, Lee JH, Chung JW, Kang B, Yoon JH,
Kim YJ, Lee HS, Jae HJ and Park JH: Transarterial chemoembolization
with additional cisplatin infusion for hepatocellular carcinoma
invading the hepatic vein. J Vasc Interv Radiol. 24:274–283. 2013.
View Article : Google Scholar : PubMed/NCBI
|
